This contract expires in 383 days (Jun 30, 2027).

Browse related active opportunities

FIRM FIXED PRICE

ROCHE DIAGNOSTICS CORPORATION - ACCU-CHECK INFORM II GLUCOSE CONTROL AND SOLUTIONS

PIID: 36C25724N0385
Signed Date: Feb 26, 2026Effective Date: Jul 3, 2024End Date: Closes in 383 days
Award $
$196K
Vendor
ROCHE DIAGNOSTICS CORPORATION
NAICS
325413
Signed Date
Feb 26, 2026

Key Details

Dollars Obligated
$195,876
Base & All Options
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
INDIANAPOLIS, IN, 462563308, CD-IN-05

Description

ACCU-CHECK INFORM II GLUCOSE CONTROL AND SOLUTIONS

Context & Analysis

On Feb 26, 2026, Department of Veterans Affairs obligated $195,876 to ROCHE DIAGNOSTICS CORPORATION for accu-check inform ii glucose control and solutions. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in INDIANAPOLIS, IN. The contract is scheduled through Jun 30, 2027 — approximately 13 months remaining.

Contractor Information

UEI: JDMDFEZBYH36
CAGE Code: 51169
Location: INDIANAPOLIS, IN

Stay Updated

Get notified about new opportunities matching your interests.

Related